⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 15, 2024Diabetes TherapyOpen Access

Association of Changes in A1C Following Continuous Glucose Monitoring Acquisition in People with Sub-Optimally Treated Type 2 Diabetes Taking GLP-1 RA Therapy

Eden Miller Joyce Chuang Gregory J. Roberts Yelena Nabutovsky Naunihal Virdi Eugene E. Wright

View Full Paper

Ask AI

Bookmark

Share

Abstract

Both glucagon-like peptide-1 receptor agonists (GLP-1 RA) and continuous glucose monitoring (CGM) improve glycemia in patients with type 2 diabetes (T2D). However, it is unknown whether adding CGM to GLP-1 RA therapy further improves A1c. We evaluated changes in A1c levels 6 months after initiation of FreeStyle Libre (FSL) in adults with sub-optimally controlled T2D already on GLP-1 RA therapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Miller et al. (2024) studied this question.

synapsesocial.com/papers/68e6035db6db64358759701c https://doi.org/10.1007/s13300-024-01619-1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Changes in HbA1c With Glucagon-Like Peptide-1 Receptor Agonist Therapy Alone and Followed by Initiation of Continuous Glucose Monitoring: A Retrospective Analysis of U.S. Medical Claims DataCohort Study · 2026
2Initiating GLP-1 Therapy in Combination with FreeStyle Libre Provides Greater Benefit Compared with GLP-1 Therapy Alone2024 · 22 citations
31917-LB: Association of FreeStyle Libre Utilization and Glycemic Outcomes among People with Type 2 Diabetes Treated with Basal Insulin and GLP-1RAs2024
41169-OR: Technology, Pharmacology, or Both? Real-World Effectiveness of CGM and GLP-1 Therapy in Primary CareCohort Study · 2026
51800-P: GLP-1 Use in Type 1 Diabetes Patients: Assessing Changes in HbA1c, Body Weight, and Cardiovascular Disease Risk ReductionOriginal Research · 2026